文献速递产科母胎医学

子痫前期中lncRNA KCNQ1OT1与miR-146a-3p的调控关系

[Regulatory relationship between lncRNA KCNQ1OT1 and miR-146a-3p in preeclampsia].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2020-01-01

研究检测子痫前期(PE)胎盘组织中KCNQ1OT1与miR-146a-3p的表达变化,并在HTR8/SVneo细胞中验证两者靶向关系及对增殖、侵袭、迁移的影响。PE组胎盘KCNQ1OT1表达低于对照组、miR-146a-3p高于对照组且呈负相关。KCNQ1OT1负调控miR-146a-3p,经CXCL12/CXCR4通路影响滋养细胞功能,可能参与PE发病。

要点

  • PE组胎盘KCNQ1OT1 mRNA低于对照组(0.23±0.03 vs 0.51±0.04,P<0.05)。
  • PE组胎盘miR-146a-3p高于对照组(0.49±0.03 vs 0.31±0.03,P<0.05),与KCNQ1OT1呈负相关(r=-0.79,P=0.031)。
  • KCNQ1OT1负调控miR-146a-3p,经CXCL12/CXCR4通路影响HTR8/SVneo细胞增殖、侵袭、迁移。

核心结论

  • KCNQ1OT1负调控miR-146a-3p的表达,激活CXCL12/CXCR4信号通路后可促进滋养细胞的增殖、迁移和侵袭,可能参与了PE的发病。

研究设计与样本

  • 选取2017年7月至2018年7月在海南省人民医院住院的PE孕妇45例为PE组,同期正常孕妇55例为对照组,采用实时荧光定量PCR检测两组胎盘组织KCNQ1OT1 mRNA与miR-146a-3p表达并分析相关性。
  • 采用HTR8/SVneo细胞先分为空白对照组和脂多糖(LPS)组,经LPS处理24 h的细胞再分为sh-KCNQ1OT1组、miR-146a-3p抑制物组和sh-KCNQ1OT1+miR-146a-3p抑制物组,共5组。
  • 用生物信息学软件预测并经双荧光素酶报告基因实验验证KCNQ1OT1与miR-146a-3p的靶向关系,用CCK-8法、划痕实验、穿膜小室实验检测细胞增殖、迁移、侵袭能力,用蛋白印迹法检测CXCL12和CXCR4蛋白表达。

主要发现

  • PE组胎盘KCNQ1OT1 mRNA低于对照组(0.23±0.03 vs 0.51±0.04,P<0.05),miR-146a-3p高于对照组(0.49±0.03 vs 0.31±0.03,P<0.05),两者呈负相关(r=-0.79,P=0.031)。
  • 与空白对照组相比,LPS组KCNQ1OT1 mRNA下降(0.91±0.03 vs 0.35±0.03,P<0.05),miR-146a-3p升高(0.22±0.03 vs 0.63±0.04,P<0.05),细胞增殖、侵袭、迁移能力及CXCL12、CXCR4蛋白表达均下降(均P<0.05)。
  • 与空白对照组相比,sh-KCNQ1OT1组KCNQ1OT1 mRNA进一步下降(0.23±0.03),miR-146a-3p进一步上升(0.85±0.03),细胞增殖、侵袭、迁移能力及CXCL12、CXCR4蛋白表达均进一步下降(均P<0.05)。
  • 与sh-KCNQ1OT1组比较,miR-146a-3p抑制物组和sh-KCNQ1OT1+miR-146a-3p抑制物组KCNQ1OT1 mRNA升高(分别为0.78±0.04、0.50±0.03),miR-146a-3p下降(分别为0.42±0.03、0.46±0.03),细胞增殖、侵袭、迁移能力及CXCL12、CXCR4蛋白表达均增高(均P<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To observe the changes of the expression level of long non-coding RNA (lncRNA) KCNQ1OT1 and microRNA (miR)-146a-3p in placenta tissues of preeclampsia (PE) patients, as well as their effect and mechanism on the biological functions of trophoblast cells. Methods: A total of 45 cases of hospitalized PE patients in Hainan General Hospital from July 2017 to July 2018 were selected as the PE group, 55 normal pregnant women during the same period were chosed as the control group. The expression level of KCNQ1OT1 mRNA and miR-146a-3p in the placenta tissues between two groups were detected by using quantitative real time (qRT)-PCR. Pearson's test was furtherly analyzed the correlation between them. Human trophoblast cell line (HTR8/SVneo) were randomly divided into control and lipopolysaccharide (LPS) groups, and then LPS group were divide into four sub-groups,included LPS group, short hairpin RNA (sh)-KCNQ1OT1 (after silencing the expression of KCNQ1OT1), miR-146a-3p inhibitor and sh-KCNQ1OT1+miR-146a-3p inhibitor. The targeting relationship between KCNQ1OT1 and miR-146a-3p were predicted by bioinformatics software and confirmed by luciferase assay. The cell proliferation and invasion capacities were respectively detected by cell counting kit-8 (CCK-8) and transwell assay. The expression level of KCNQ1OT1 mRNA and miR-146a-3p were detected by qRT-PCR and the protein expression level of CXC chemokine ligand 12 (CXCL12) and CXC chemokine receptor type 4 (CXCR4) were tested by western blot. Results: (1) The mRNA expression level of KCNQ1OT1 in the placenta of PE group was lower than that of control group (0.23±0.03 vs 0.51±0.04, P<0.05), and the miR-146a-3p expression level was higher than that of the control group (0.49±0.03 vs 0.31±0.03, P<0.05), there were statistical significant differences between the two groups. (2) Luciferase assay showed that there was a targeting relationship between KCNQ1OT1 and mir-146a-3p. Compared with the control group, the mRNA expression level of KCNQ1OT1 in the LPS group were significantly decreased (0.91±0.03 vs 0.35±0.03, P<0.05), and the expression level of miR-146a-3p were significantly increased (0.22±0.03 vs 0.63±0.04, P<0.05). The cell proliferation, invasion and migration capacities and the protein expression of CXCL12 and CXCR4 significantly reduced in the LPS group compared with control group (all P<0.05). The mRNA expression level of KCNQ1OT1 (0.23±0.03) in the sh-KCNQ1OT1 group were further decreased, the expression of miR-146a-3p (0.85±0.03) were further increased, and the cell proliferation, invasion and migration capacities and the protein expression of CXCL12 and CXCR4 were all further reduced compared with control group,there were significant difference between two groups (all P<0.05). Comparing the miR-146a-3p inhibitor group, and sh-KCNQ1OT1+miR-146a-3p inhibitor group with the sh-KCNQ1OT1 group, respectively, the expression level of KCNQ1OT1 mRNA (0.78±0.04 vs 0.50±0.03) increased, and the expression level of miR-146a-3p (0.42±0.03 vs 0.46±0.03) decreased, the cell proliferation, invasion and migration capacities and the protein expression of CXCL12 and CXCR4 were all increased ,there were statistically significant differences (all P<0.05). Conclusion: KCNQ1OT1 could target the regulation of miR-146a-3p through CXCL12/CXCR4 pathway in the proliferation, invasion an migration of HTR8/SVneo cells, which may be involved in the pathogenesis of PE. 目的: 观察长链非编码RNA(lncRNA)钾电压门控通道亚家族Q成员1反向转录物1(KCNQ1OT1)和微小RNA(miR)-146a-3p在子痫前期(PE)胎盘组织中的表达,并初步探索两者相互调控后对滋养细胞生物学特性的影响及作用机制。 方法: (1)选择2017年7月—2018年7月在海南省人民医院住院的PE孕妇45例为PE组,选择同期正常孕妇55例为对照组,采用实时荧光定量PCR技术检测两组胎盘组织中KCNQ1OT1 mRNA、miR-146a-3p的表达,并分析两者的相关性。(2)采用绒毛膜滋养细胞层细胞系HTR8/SVneo细胞,先分为空白对照组和脂多糖(LPS)组,经LPS处理24 h的HTR8/SVneo细胞再进一步分为短发夹状RNA(sh)-KCNQ1OT1组(即沉默KCNQ1OT1的表达)、miR-146a-3p抑制物(inhibitor)组和sh-KCNQ1OT1+miR-146a-3p inhibitor组,共5组。应用生物信息学软件预测KCNQ1OT1和miR-146a-3p的靶向关系,并采用双荧光素酶报告基因实验加以验证;分别采用活细胞计数(CCK-8)法、划痕实验、穿膜(transwell)小室实验检测HTR8/SVneo细胞的增殖、迁移、侵袭能力,实时荧光定量PCR技术检测细胞中KCNQ1OT1 mRNA、miR-146a-3p的表达,蛋白印迹(western blot)法检测细胞中趋化因子12(CXCL12)和趋化因子受体4(CXCR4)蛋白的表达。 结果: (1)PE组胎盘组织中KCNQ1OT1 mRNA的表达水平低于对照组(分别为0.23±0.03、0.51±0.04),miR-146a-3p的表达水平高于对照组(分别为0.49±0.03、0.31±0.03),两组分别比较,差异均有统计学意义(P<0.05);PE组胎盘组织中KCNQ1OT1 mRNA的表达水平与miR-146a-3p的表达水平呈负相关(r=-0.79,P=0.031)。(2)生物信息学软件预测并经双荧光素酶报告基因实验验证显示,KCNQ1OT1与miR-146a-3p存在靶向关系。与空白对照组相比,LPS组细胞中KCNQ1OT1 mRNA的表达水平下降(分别为0.91±0.03、0.35±0.03),miR-146a-3p的表达水平升高(分别为0.22±0.03、0.63±0.04),细胞的增殖、侵袭、迁移能力及CXCL12、CXCR4蛋白的表达均下降,分别比较,差异均有统计学意义(P<0.05);sh-KCNQ1OT1组细胞中KCNQ1OT1 mRNA的表达水平(0.23±0.03)进一步下降,miR-146a-3p的表达水平(0.85±0.03)进一步上升,细胞的增殖、侵袭、迁移能力及CXCL12、CXCR4蛋白的表达均进一步下降,分别比较,差异均有统计学意义(P<0.05);而miR-146a-3p inhibitor组、sh-KCNQ1OT1+miR-146a-3p inhibitor组分别与sh-KCNQ1OT1组比较,KCNQ1OT1 mRNA的表达水平(分别为0.78±0.04、0.50±0.03)升高,miR-146a-3p的表达水平(分别为0.42±0.03、0.46±0.03)下降,细胞的增殖、侵袭、迁移能力及CXCL12、CXCR4蛋白的表达均增高,分别比较,差异均有统计学意义(P<0.05)。 结论: KCNQ1OT1负调控miR-146a-3p的表达,激活CXCL12/CXCR4信号通路后,可促进滋养细胞的增殖、迁移和侵袭,可能参与了PE的发病。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Chen FR, Zheng LM, Wu DC, et al. [Regulatory relationship between lncRNA KCNQ1OT1 and miR-146a-3p in preeclampsia]. Zhonghua Fu Chan Ke Za Zhi. 2020. PMID: 32854478. doi:10.3760/cma.j.cn112141-20200322-00246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。